Neha Krishnamohan
Director/Board Member bei ARCUTIS BIOTHERAPEUTICS, INC.
Vermögen: 55 565 $ am 31.03.2024
Profil
Neha Krishnamohan is an Independent Director at Arcutis Biotherapeutics, Inc. She previously worked as a Vice President-Healthcare Investment Banking at The Goldman Sachs Group, Inc. from 2015 to 2021.
She also served as the CFO & Executive VP-Corporate Development at Kinnate Biopharma, Inc. from 2021 to 2024.
Ms. Krishnamohan completed her undergraduate degree at Duke University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
31.05.2023 | 5 607 ( 0,00% ) | 55 565 $ | 31.03.2024 | |
KINNATE BIOPHARMA, INC.
-.--% | 03.04.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Neha Krishnamohan
Unternehmen | Position | Beginn |
---|---|---|
ARCUTIS BIOTHERAPEUTICS, INC. | Director/Board Member | 02.09.2022 |
Ehemalige bekannte Positionen von Neha Krishnamohan
Unternehmen | Position | Ende |
---|---|---|
KINNATE BIOPHARMA INC. | Director of Finance/CFO | 03.04.2024 |
THE GOLDMAN SACHS GROUP, INC. | Corporate Officer/Principal | 01.05.2021 |
Ausbildung von Neha Krishnamohan
Duke University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
THE GOLDMAN SACHS GROUP, INC. | Finance |
ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Kinnate Biopharma, Inc.
Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |